mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |